Machine Learning Prediction of Protein Adsorption on Drug-delivering Nanoparticles: A Literature Survey and Need for Future Development

Nanoparticles (NPs), due to their small size and large surface area, have advanced their use as drug carriers for delivering various therapeutic molecules. When entering biological environments, nanoparticles typically adsorb proteins, forming a surface layer known as a protein corona that significantly affects the biological and therapeutic functions of a delivery system. Understanding and predicting protein adsorption is essential for optimizing nanoparticle design in drug delivery, diagnostics, and therapy. Machine learning and deep learning (ML/DL) offer promising methods for designing nanoparticles with specific properties, particularly given recent advancements in computation and nanoparticle analysis. This review explores ML/DL studies of nanoparticle-protein interactions and emphasizes the popularity of Random Forest (RF) and Deep Learning (DL) models in predicting protein corona compositions. RF models are highly valued for managing high-dimensional data and offering interpretability, which helps identify key NP features influencing protein adsorption. Conversely, DL excels at modeling non-linear relationships and detecting subtle interaction patterns. While most current research focuses on protein coronas, future models may also include other biocorona components. This is particularly relevant for soft materials, such as lipid nanoparticles (LNPs), which are now approved for delivering mRNA and peptide-based vaccines. Our findings underscore the need for advanced modeling techniques and high-quality, diverse experimental data to drive innovations in nanomedicine. Combining RF and DL approaches leverages their complementary strengths to overcome the challenge of limited experimental data and further improve NP designs for biomedical use.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Research
Published
2025-11-26
DOI
https://doi.org/10.1007/s11095-025-03981-6
Citations
3
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
2.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Machine Learning Prediction of Protein Adsorption on Drug-delivering Nanoparticles: A Literature Survey and Need for Future Development

Tonglei Li, Koushiki Basu, Venkata S. Chelagamsetty, Veronica A. Ruiz-Avila
3 citations
Pharmaceutical Research
Advanced Drug Delivery Systems
2.37
article

Machine Learning Prediction of Protein Adsorption on Drug-delivering Nanoparticles: A Literature Survey and Need for Future Development

Tonglei Li, Koushiki Basu, Venkata S. Chelagamsetty, Veronica A. Ruiz-Avila
article en
3 citations

Abstract

Nanoparticles (NPs), due to their small size and large surface area, have advanced their use as drug carriers for delivering various therapeutic molecules. When entering biological environments, nanoparticles typically adsorb proteins, forming a surface layer known as a protein corona that significantly affects the biological and therapeutic functions of a delivery system. Understanding and predicting protein adsorption is essential for optimizing nanoparticle design in drug delivery, diagnostics, and therapy. Machine learning and deep learning (ML/DL) offer promising methods for designing nanoparticles with specific properties, particularly given recent advancements in computation and nanoparticle analysis. This review explores ML/DL studies of nanoparticle-protein interactions and emphasizes the popularity of Random Forest (RF) and Deep Learning (DL) models in predicting protein corona compositions. RF models are highly valued for managing high-dimensional data and offering interpretability, which helps identify key NP features influencing protein adsorption. Conversely, DL excels at modeling non-linear relationships and detecting subtle interaction patterns. While most current research focuses on protein coronas, future models may also include other biocorona components. This is particularly relevant for soft materials, such as lipid nanoparticles (LNPs), which are now approved for delivering mRNA and peptide-based vaccines. Our findings underscore the need for advanced modeling techniques and high-quality, diverse experimental data to drive innovations in nanomedicine. Combining RF and DL approaches leverages their complementary strengths to overcome the challenge of limited experimental data and further improve NP designs for biomedical use.

Pharmaceutical ResearchVol. 43(1)
Purdue University West Lafayette (US)
Eli Lilly and Company
Openalex Percentile: Top 10%
Advanced Drug Delivery Systems
2.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.